181 related articles for article (PubMed ID: 32779876)
1. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract][Full Text] [Related]
2. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
4. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
[No Abstract] [Full Text] [Related]
6. Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53.
Wang G; Sheng W; Shi X; Li X; Zhou J; Dong M
FEBS J; 2019 May; 286(9):1668-1682. PubMed ID: 30724469
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
8. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
Oncotarget; 2017 Feb; 8(9):14359-14373. PubMed ID: 27092875
[TBL] [Abstract][Full Text] [Related]
9. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.
Yan Z; Ohuchida K; Zheng B; Okumura T; Takesue S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
J Cancer Res Clin Oncol; 2019 May; 145(5):1147-1164. PubMed ID: 30770989
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
Yang H; Hu J; Chen J; Chen Z; Jiao F; Cui J; Quan M; Wang L
Med Oncol; 2020 Aug; 37(9):84. PubMed ID: 32780197
[TBL] [Abstract][Full Text] [Related]
11. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
[TBL] [Abstract][Full Text] [Related]
12. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
[TBL] [Abstract][Full Text] [Related]
13. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma.
Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J
Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981
[TBL] [Abstract][Full Text] [Related]
15. Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.
Sheng W; Shi X; Lin Y; Tang J; Jia C; Cao R; Sun J; Wang G; Zhou L; Dong M
J Exp Clin Cancer Res; 2020 Jan; 39(1):16. PubMed ID: 31952541
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis.
Wang W; Wang J; Yang C; Wang J
IUBMB Life; 2021 Jun; 73(6):866-882. PubMed ID: 33759343
[TBL] [Abstract][Full Text] [Related]
17. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of STAT1 and p21 proteins predicts pancreatic cancer progression and prognosis.
Sun Y; Yang S; Sun N; Chen J
Pancreas; 2014 May; 43(4):619-23. PubMed ID: 24658320
[TBL] [Abstract][Full Text] [Related]
20. Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.
Yang C; Zhang W; Wang L; Kazobinka G; Han X; Li B; Hou T
Lab Invest; 2016 Sep; 96(9):950-8. PubMed ID: 27322953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
